If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £95.93m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Trading Update

13 Oct 2016 07:00

RNS Number : 4035M
Iofina PLC
13 October 2016
 

 

13 October 2016

 

Iofina plc

("Iofina", the "Group" or the "Company")

(LSE AIM: IOF)

 

Q3 Production & Corporate Update

On track to meet production targets for H2 2016

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to update the market today on the Company's Q3 iodine production.

The Group produced 125.1 metric tonnes ("MT") of crystalline iodine in Q3 2016 (the "Period"), and has produced 380.7 MT year to date from our five IOsorb® plants in Oklahoma. The Group remains on track to meet our production targets of 250-270 MT of crystalline iodine in H2 2016. As recently communicated, Iofina and its partners have completed improvement projects at three plants during the Period. The design improvements will provide a more consistent brine input to our IOsorb® plants, which is necessary under a changing regulatory environment. Iofina continues to work closely with its partners on a variety of strategies to maximise productive throughput at all of its IOsorb® plants.

In addition, Iofina Chemical has performed well in a competitive market, selling the Company's IOflo® iodine along with Iofina's portfolio of iodine and specialty halogen derivatives, to customers worldwide. 

 

Commenting on today's update, President and CEO Dr. Tom Becker, stated:

"Our five IOsorb® plants continue to produce on a reliable basis in line with Company forecasts. Improvements to brine tie-ins and other measures will help ensure consistency of raw brine for the future."

 

For further information, please contact:

 

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Joanna Scott

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Dominic Barretto/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7544 275 882

 

About Iofina:

Iofina specialises in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilises its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDIILFLIR
Date   Source Headline
6th Jun 201712:02 pmRNSPrice Monitoring Extension
24th May 20174:40 pmRNSSecond Price Monitoring Extn
24th May 20174:35 pmRNSPrice Monitoring Extension
24th May 201712:07 pmRNSSecond Price Monitoring Extn
24th May 201712:02 pmRNSPrice Monitoring Extension
19th May 20177:00 amRNSFinal Results and Notice of AGM
3rd May 20174:41 pmRNSSecond Price Monitoring Extn
3rd May 20174:35 pmRNSPrice Monitoring Extension
25th Apr 20174:40 pmRNSSecond Price Monitoring Extn
25th Apr 20174:35 pmRNSPrice Monitoring Extension
11th Apr 20177:00 amRNSTrading Update
3rd Apr 20177:00 amRNSProduction update
14th Feb 20174:35 pmRNSPrice Monitoring Extension
13th Jan 20177:00 amRNSCorporate Update
13th Dec 20164:35 pmRNSPrice Monitoring Extension
12th Dec 20167:00 amRNSCorporate update
2nd Dec 20167:00 amRNSChange of Registered Office
4th Nov 20167:00 amRNSDirectorate Change
13th Oct 20167:00 amRNSTrading Update
30th Sep 20167:00 amRNSCompletion of Debt Restructure
30th Sep 20167:00 amRNSInterim Results
12th Sep 20164:35 pmRNSPrice Monitoring Extension
17th Aug 20164:40 pmRNSSecond Price Monitoring Extn
17th Aug 20164:35 pmRNSPrice Monitoring Extension
11th Aug 20161:33 pmRNSWater Depot Permit Update
25th Jul 20164:40 pmRNSSecond Price Monitoring Extn
25th Jul 20164:35 pmRNSPrice Monitoring Extension
11th Jul 20167:00 amRNSCorporate and Production Update
7th Jun 201611:37 amRNSResult of AGM
7th Jun 20167:00 amRNSRestructure of Debt
9th May 20167:00 amRNSFinal Results and Notice of AGM
11th Apr 20167:00 amRNSMarket update
15th Feb 20167:00 amRNSDirectorate Change
18th Jan 20167:00 amRNSCorporate Update
14th Dec 20157:00 amRNSTrading Update
23rd Nov 20157:00 amRNSBrine Supply Update
28th Oct 20157:00 amRNSAppointment of CFO
15th Oct 20159:00 amRNSIofina becomes founding member of the WIA
9th Oct 20157:00 amRNSProduction and Corporate Update
5th Oct 20151:59 pmRNSChange of Registered Office
29th Sep 20157:00 amRNSInterim Results
14th Jul 20157:00 amRNSCorporate & Trading Update
22nd Jun 20155:41 pmRNSHolding(s) in Company
19th Jun 201512:05 pmRNSResult of AGM
16th Jun 20157:00 amRNSProduction Update
5th Jun 20157:00 amRNSWater Depot Permit Update
27th May 20157:00 amRNSFinal Results and Notice of AGM
11th May 20157:00 amRNSAnnouncement of Final Results
22nd Apr 20157:00 amRNSChange of Adviser
15th Apr 20157:00 amRNSProduction Update & Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.